A National Securities Arbitration & Investment Fraud Law Firm

$70 MILLION Recovery for Investment Fraud
$44 MILLION Recovery for Ponzi Scheme Victims
$25 MILLION Recovery Against National Brokerage Firm
$9.1 MILLION FINRA Arbitration Award Against Brokerage Firm
$7.9 MILLION Securities Arbitration Award Against Stockbroker
$1 MILLION Securities Arbitration Award for Elder Financial Fraud
American Association for Jusice
Florida Legal Elite 2011
Legal Leaders
5th Annual Most Effective Lawyers 2009
Multi-Million Dollar Advocates Forum
Super-Lawyers
SFLG
Top 100
Public Justice

|

“FINRA Office of Dispute Resolution” (a/k/a ODR or DR) has changed its name to “FINRA Dispute Resolution Services”. A newsletter from FINRA says the name change “highlights our focus on customer service and helps distinguish FINRA Dispute Resolution Services from FINRA Enforcement for our external stakeholders, lawmakers and the media. The name change also highlights our unique functions and speaks to our role as a neutral administrator of FINRA’s arbitration and mediation forum.” Richard Berry, FINRA’s Executive Vice President and Director of Dispute Resolution, says the name change represents that his office administers disputes, rather than resolves them. FINRA, the Financial Industry Regulatory Authority, is a government-authorized non-profit organization that works under the Securities and Exchange Commission (SEC) to protect investors and ensure market integrity. Authorized by Congress, FINRA oversees over 4,200 broker-dealers and more than 624,000 brokers.“FINRA Office of Dispute Resolution” (a/k/a ODR or DR) has changed its name to “FINRA Dispute Resolution Services”. A newsletter from FINRA says the name change “highlights our focus on customer service and helps distinguish FINRA Dispute Resolution Services from FINRA Enforcement for our external stakeholders, lawmakers and the media. The name change also highlights our unique functions and speaks to our role as a neutral administrator of FINRA’s arbitration and mediation forum.” Continue reading ›

|

Silver Law Group is investigating Aquestive Therapeutics, Inc. (AQST) regarding potential violations of federal securities laws. If you have losses from investing in Aquestive Therapeutics, Inc. (AQST) stock, contact Silver Law Group for consultation at no cost at (800) 975-4345 or by email at ssilver@silverlaw.com. Aquestive Therapeutics, Inc. (AQST) Drug Libervant Aquestive Therapeutics, Inc. (AQST) is a specialty pharmaceutical company based out of New Jersey that “focuses on identifying, developing, and commercializing various products to address unmet medical needs.” On September 25, 2020, Aquestive said that it had received a Complete Response Letter (CRL) from the Food and Drug Administration (FDA) for its New Drug Application for Libervant Buccal Film. Libervant is a drug being developed to manage seizure clusters.Silver Law Group is investigating Aquestive Therapeutics, Inc. (AQST) regarding potential violations of federal securities laws.

If you have losses from investing in Aquestive Therapeutics, Inc. (AQST) stock, contact Silver Law Group for consultation at no cost at (800) 975-4345 or by email at ssilver@silverlaw.com. Continue reading ›

|

Robert Buffington (CRD#:5220332) is a previously registered broker whose last employer was Aegis Capital Corp. (CRD# 15007) of New York, NY. Prior employers include Gunnallen Financial, Inc (CRD#:17609), Maxim Group LLC (CRD#:120708) and Bear, Stearns & Co. Inc. (CRD#:79), all of New York. He has been in the industry since 2007. No current employment information is available. Buffington is the subject of four disclosures, all customer disputes. The most recent was filed on 3/9/2020, with allegations of unsuitability, and breaches of contract and fiduciary duty in an unspecified time frame. This dispute requests damages of $642,224.00. Two previous disputes were filed on 1/17/2020 and 1/21/2020, respectively. Both contain allegations of unsuitability, churning, common law fraud, and breaches of contract and fiduciary duty. The dispute filed on 1/17 claims a timeframe of November 2018 through the present. The other dispute has an unspecified time frame. All three of these disputes are pending.Robert Buffington (CRD#:5220332) is a previously registered broker whose last employer was Aegis Capital Corp. (CRD# 15007) of New York, NY. Prior employers include Gunnallen Financial, Inc (CRD#:17609), Maxim Group LLC (CRD#:120708) and Bear, Stearns & Co. Inc. (CRD#:79), all of New York. He has been in the industry since 2007. No current employment information is available. Continue reading ›

|

Marcello Lattuca (CRD: #2149434) is a registered broker currently registered with NBC Securities (CRD: #17870) in Massapequa, NY. His previous employers include JHS Capital Advisors, LLC (CRD#:112097), also of Massapequa, Gunnallen Financial, Inc. (CRD#:17609) of Plainview NY, and Kirlin Securities Inc. (CRD#:21210, expelled by FINRA in 2009) of Syosset, NY. He has been in the industry since 1991. NBC Securities promotes itself as a full service broker/dealer and registered investment advisor providing investment services to retail and institutional clients. We offer financial advice and solutions through a diverse menu of investment products and services.Marcello Lattuca (CRD: #2149434) is a registered broker currently registered with NBC Securities (CRD: #17870) in Massapequa, NY. His previous employers include JHS Capital Advisors, LLC (CRD#:112097), also of Massapequa, Gunnallen Financial, Inc. (CRD#:17609) of Plainview NY, and Kirlin Securities Inc. (CRD#:21210, expelled by FINRA in 2009) of Syosset, NY. He has been in the industry since 1991. Continue reading ›

|

Silver Law Group is investigating Zosano Pharma Corporation (ZSAN) regarding potential violations of federal securities laws. If you have losses from investing in Zosano Pharma Corporation (ZSAN), please contact Silver Law Group for a no cost consultation at (800) 975-4345 or by email at ssilver@silverlaw.com. Zosano Pharma Corporation is a biopharmaceutical company headquartered in California that provides “therapeutics to patients suffering from migraine using its Adhesive Dermally-Applied Microarray technology.” Zosano’s lead product candidate is called Qtrypta, which is a formulation of zolmitriptan to treat migraines.Silver Law Group is investigating Zosano Pharma Corporation (ZSAN) regarding potential violations of federal securities laws.

If you have losses from investing in Zosano Pharma Corporation (ZSAN), please contact Silver Law Group for a no cost consultation at (800) 975-4345 or by email at ssilver@silverlaw.com. Continue reading ›

|

Grant Cardone, the popular social media influencer, real estate investor, and sales trainer, is being sued in a class action lawsuit which alleges that he and his company made false and misleading statements and omitted material facts to investors in relation to Cardone Capital LLC’s public offerings in Cardone Equity Fund V, LLC and Cardone Equity Fund VI, LLC. Cardone Capital, LLC And Cardone Equity Fund V & VI Cardone Capital, LLC markets itself as providing real estate investment opportunities to investors through crowdfunding. The company states that it uses investors’ money to buy properties that generate rental income, which it uses to pay cash distributions to investors.Grant Cardone, the popular social media influencer, real estate entrepreneur, and sales trainer, is being sued in a class action lawsuit which alleges that he and his company made false and misleading statements and omitted material facts to investors in relation to Cardone Capital LLC’s public offerings in Cardone Equity Fund V, LLC and Cardone Equity Fund VI, LLC. Continue reading ›

|

Grant Cardone and his investment firm Cardone Capital have come under serious scrutiny this year following revelations about his business model that may lead to losses in Cardone’s real estate “empire” and leaving investors with substantial losses. Cardone Capital, launched in 2017, markets its business model as follows: first, Cardone Capital finds real estate opportunities and negotiates and closes their purchase and financing, second, investors become partners in the real estate projects, third, the properties generate rent, and fourth, the Cardone funds pay cash distributions to investors (see the “How it works?” section of Cardone Capital’s website). Cardone Capital’s website boasts a portfolio of multi-tenant properties across the United States.Grant Cardone and his investment firm Cardone Capital have come under serious scrutiny this year following revelations about his business model that may lead to losses in Cardone’s real estate “empire” and leaving investors with substantial losses.

Cardone Capital, launched in 2017, markets its business model as follows: first, Cardone Capital finds real estate opportunities and negotiates and closes their purchase and financing, second, investors become partners in the real estate projects, third, the properties generate rent, and fourth, the Cardone funds pay cash distributions to investors (see the “How it works?” section of Cardone Capital’s website). Cardone Capital’s website boasts a portfolio of multi-tenant properties across the United States. Continue reading ›

|

Cardone Capital, LLC and its CEO Grant Cardone, a social media influencer, author, and real estate investor, are the subject of a class action lawsuit filed on behalf of investors. The lawsuit alleges Cardone and his company made false and misleading statements and omitted material facts related to public offerings of interest in Cardone Equity Fund V and Cardone Equity Fund VI.Cardone Capital, LLC and its CEO Grant Cardone, a social media influencer, author, and real estate investor, are the subject of a class action lawsuit filed on behalf of investors. The lawsuit alleges Cardone and his company made false and misleading statements and omitted material facts related to public offerings of interest in Cardone Equity Fund V and Cardone Equity Fund VI. Continue reading ›

|

Silver Law Group is investigating Nano-X Imaging Ltd. (NNOX) on behalf of investors in the company. The investigation concerns whether the company violated federal securities laws. If you have information relating to this investigation and/or investment losses with Nano-X Imaging Ltd. (NNOX), contact Silver Law Group for a no cost consultation at (800) 975-4345 or by email at ssilver@silverlaw.com. Nano-X Imaging Ltd. (NNOX) is a company based in Israel that develops and produces X-ray technology for medical imaging. On September 15, 2020, Citron Research released a report with the title “Nano-X (NNOX) A Complete Farce on the Market.” The Citron report described problems with the company, and stated that “this $3 billion company is nothing more than a science project with a simple rendering minimal  R&D, fake customers, no FDA approval, and fraudulent claims that are beyond the realm of possibility.”Silver Law Group is investigating Nano-X Imaging Ltd. (NNOX) on behalf of investors in the company. The investigation concerns whether the company violated federal securities laws.

If you have information relating to this investigation and/or investment losses with Nano-X Imaging Ltd. (NNOX), contact Silver Law Group for a no cost consultation at (800) 975-4345 or by email at ssilver@silverlaw.com. Continue reading ›

|

Silver Law Group is investigating Nikola Corporation (NKLA) regarding possible securities fraud, and may file a class action on behalf of investors. If you have losses from investing in Nikola Corporation (NKLA) stock, contact Silver Law Group for consultation at no cost at (800) 975-4345 or by email at ssilver@silverlaw.com. Silver Law Group can provide a complimentary case evaluation and discuss investors’ options for pursuing claims to recover their losses. Nikola Accused Of Being A Fraud Nikola Corporation is an American company with plans to produce zero emissions vehicles. The company has gained much attention for its high-flying stock and $12.4 billion market capitalization despite having delivered no vehicles. On September 10, 2020, investment analyst Hindenburg Research published a report on Nikola Corporation entitled ‘Nikola: How to Parlay An Ocean of Lies Into a Partnership With the Largest Auto OEM in America’.Silver Law Group is investigating Nikola Corporation (NKLA) regarding possible securities fraud, and may file a class action on behalf of investors.

If you have losses from investing in Nikola Corporation (NKLA) stock, contact Silver Law Group for consultation at no cost at (800) 975-4345 or by email at ssilver@silverlaw.com. Silver Law Group can provide a complimentary case evaluation and discuss investors’ options for pursuing claims to recover their losses. Continue reading ›

Contact Information
Main Office
11780 W Sample Rd
Coral Springs, FL 33065
Phone: (954) 755-4799Fax: (954) 755-4684
New York Office
229 W 36th St 8th Floor
New York, NY 10018
Phone: (212) 377-5227
Florida Office
4755 Technology Way #205
Boca Raton, FL 33431
Phone: (561) 665-8613
ATTORNEY ADVERTISING

Visit our Florida Securities Whistleblower Website

We serve clients nationwide including, but not limited to, those in the following localities: Atlanta, Baltimore, Boston, Chicago, Dallas–Fort Worth, Denver, Detroit, Houston, Los Angeles, Miami, New York City, Philadelphia, Phoenix, San Bernardino-Riverside, San Diego, San Francisco, Seattle, St. Louis, Tampa–St. Petersburg, and Washington, D.C. View More

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Please do not include any confidential or sensitive information in a contact form, text message, or voicemail. The contact form sends information by non-encrypted email, which is not secure. Submitting a contact form, sending a text message, making a phone call, or leaving a voicemail does not create an attorney-client relationship.

Copyright © 2025, Silver Law Group
JUSTIA Law Firm Blog Design